Quote:

---

Buspirone (BuSpar) Patent protection of this drug expired November 22, 2000. To hold off generic competition, BMS filed for patent protection for the chemical produced inside the human body when a person ingests BuSpar. This was a new legal strategy, but it could have blocked entry of generics (expected to lower the price up to 75%) until the year 2020. On March 14, a federal judge ordered the FDA to approve generic BuSpar.

---

this is from Bristol-Myers Squibb. evidently the patent was supposed to expire in 1998 but they got a 2 year extension. i'm not sure if they got another extension after that but it was attempted (is being attempted???)

it's been so long since i have taken that i don't remember how effective it was for me. may be of interest to the original poster, however, might be something she could discuss with her doctor.

lexapro, i am not familiar with. wellbutrin (also immediate release), i was taking 400mgs/day now i'm down to 300mgs/day. as it contains amphetamine-like derivatives i do not think that this would be effective for her.

the patent extension i have attached is for the buspar.

congrats on your first post, tenor. it was a very good one. looking forward to more.

cheers, c.(angel)



--------------------
"Some mornings, it's just not worth chewing through the leather straps."
Emo Philips.

Post Extras